Related Experiment Videos
Individual differences in novelty seeking on the playground maze predict amphetamine conditioned place preference
1University of Kentucky, Department of Psychology, Lexington 40506-0044, USA.
Pharmacology, Biochemistry, and Behavior
|May 26, 1999
Summary
Novelty seeking in rats predicts amphetamine reward, not activity. High novelty seekers showed greater amphetamine-conditioned place preference, suggesting a link between exploring new environments and drug reward mechanisms.
Area of Science:
- Neuroscience
- Behavioral Pharmacology
Background:
- Novelty seeking behavior in rodents can predict responses to drugs like amphetamine.
- Previous studies indicate a disconnect between novelty-induced activity and amphetamine-conditioned place preference.
Purpose of the Study:
- To investigate the predictive value of a novel playground maze test for individual differences in amphetamine response.
- To determine if novelty seeking behavior correlates with amphetamine-conditioned place preference and locomotor activity.
Main Methods:
- Rats were assessed for novelty seeking using the playground maze.
- Individual differences in novelty seeking were used to categorize rats as high or low novelty seekers.
- The effects of amphetamine (1 and 3 mg/kg) on locomotor activity and conditioned place preference were measured.
Main Results:
- Individual differences in novelty seeking did not predict amphetamine-induced locomotor activity after single or repeated injections.
- High novelty-seeking rats exhibited a significantly greater amphetamine-conditioned place preference compared to low novelty-seeking rats.
- These findings suggest a specific relationship between novelty seeking and the rewarding effects of amphetamine.
Conclusions:
- The playground maze effectively categorizes rats based on novelty-seeking behavior.
- Novelty seeking is a predictor of amphetamine-conditioned place preference, but not amphetamine-induced locomotor activity.
- Results support a neuropharmacological link between novelty seeking and drug reward pathways.